It was found that human aortic endothelial cells subjected to hyperglycemia show increased NOX1 expression and increased ROS production, while the use of a NOX1 inhibitor reduces ROS production, the expression of adhesion molecules, and the infiltration of the vessel wall by inflammatory cells [48]. Here, NOX1 is linked to Hyperglycemia.